Rising Substance Abuse Among Pregnant Women Leads to Neonatal Abstinence Syndrome

Argentina is facing a growing crisis as an increasing number of pregnant women are struggling with substance addiction, leading to newborns experiencing withdrawal symptoms. This condition, often silent and asymptomatic, can tragically result in sudden infant death. The nine months of gestation are critical for fetal development, and maternal drug or alcohol consumption poses severe risks, as substances can cross the placenta and harm the fetus. The most vulnerable demographic to substance use is women of reproductive age. The Argentine Society of Pediatrics (SAP) has highlighted a surge in dangerous substance use during pregnancy and breastfeeding, with medical professionals detecting cocaine, synthetic drugs, cannabis, and psychotropic medications in both expectant mothers and newborns. Obstetric services in the Buenos Aires metropolitan area report that between 8% and 15% of pregnant patients consume substances. Many women conceal their addiction due to social stigma or fear of legal repercussions, and routine screenings for drug use are not standard medical practice. This lack of early detection means that potential interventions are missed, and healthcare providers may not be equipped to manage the complex needs of infants born with withdrawal symptoms. In some hospitals, these cases are not handled adequately, contributing to infant mortality. While some provinces are beginning to implement universal screening, such as Mendoza where over 10% of pregnant women show problematic substance use, data collection remains inconsistent nationwide. In Mendoza, nearly 20% of newborns test positive for toxins, impacting infant mortality rates. Experts urge the nationwide adoption of routine testing to allow for timely interventions before birth. This escalating public health issue is compounded by some mothers abandoning their infants post-delivery to continue their addiction, jeopardizing the future of the nation's children.